by Andy Martin | Aug 15, 2023
In this article we expand upon the equipment section but looking at Utilities as described in section 6. The level of control of Utilities such as water, steam, compressed gases and so on depends on risk which should be documented in the contamination control...
by Andy Martin | Aug 11, 2023
In the last article, I described the premises requirements for sterile product manufacture. In this article we look at the general requirements for the equipment used in the manufacturing of sterile products. Depending on the complexity of the equipment Annex 1...
by Andy Martin | Aug 8, 2023
In this fourth article I shall explore Section 3, the Pharmaceutical Quality System. This is a short section aimed at highlighting the additional requirements beyond those also required from EU GMP chapter 1. It is important to remind ourselves that Annexes are...
by Andy Martin | Jul 29, 2023
In the last article, I discussed the scope of the latest update to Annex 1. In this article I want to focus on section 2, “Principle”. The fundamental basis upon which Annex 1 is now build is written into the principle and its associated clauses. It covers elements of...
by Andy Martin | Jul 28, 2023
In the first article I summarised the background to the latest update to Annex 1. In this article I want to focus on sections 1, “Scope”. The scope of a document is usually intended to outline the range of application of the document. It can be used to summarise areas...
by Andy Martin | Jul 19, 2023
Annex 1 has finally arrived, 25th Aug 2022 saw the publication of Annex 1. Normally, updates to GMP chapters and Annexes have a 6-month lead time for implementation. In the case of the new Annex 1, the lead time is 12 months, except for clause 8.123 relating to...